SHARE brings together the expertise of Barts Health NHS Trust, Barts and The London School of Medicine and Dentistry and Queen Mary University of London to investigate the inequalities that are ...

At Queen Mary University of London, we are deeply committed to being an institution that is connected to communities where our work has an impact: from east London to Rio de Janeiro. We strive to ...

Ultimately, the research led by Dr Zubiaga emphasises that trustworthy AI in hate speech detection depends on better dataset design, interdisciplinary collaboration, and ethical oversight. Improving ...

A major UK study has revealed that the early warning signs of multiple sclerosis (MS) - including pain, mood changes, and ...

Our programmes teach you to think beyond textbooks, management fads and memorised formulas for success – where the focus is on social justice, sustainability, and good governance to create tomorrow’s ...

On 17 September 2025, Queen Mary University of London signed a five-year partnership with Thailand’s Office of the Civil ...

In the 2025 Knowledge Exchange Framework (KEF5) results, published today, Queen Mary University of London has maintained the highest possible score for the categories 'IP and commercialisation, ...

The Centre for Public Engagement Small Grants funding programme provides grants of up to £1,000 to enable Queen Mary staff and students to deliver small-scale projects that engage the public with ...

The 2015 Survey ‘Improvements and Innovations in International Arbitration’, is the sixth carried out by the School of International Arbitration at Queen Mary University of London, as part of a major ...

Excel in corporate finance with the BSc Accounting and Finance programme at Queen Mary University of London. Benefit from proximity to London’s financial hub, cutting-edge resources like Bloomberg and ...

Queen Mary is celebrating our postdocs and the contributions they make to research, impact, and culture during National ...

Researchers from Queen Mary University of London have developed and validated a new tool that could help GPs detect ovarian cancer earlier and improve patient outcomes cost-effectively.